Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2018

01.10.2018 | Research Article

Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic

verfasst von: Hua Cao, Jianmei Wu, Jinhua Zhang

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background In response to the recognized difficulty in the management of patients on anticoagulation therapy, anticoagulation management services were developed in both hospital anticoagulation clinics (HACs) and an online anticoagulation clinic (OAC) by a pharmacist. Objective To compare monitoring outcomes and complications of warfarin therapy managed by pharmacists via hospital or on-line. Setting The anticoagulation clinic of Fujian Medical University Union Hospital, China. Method A retrospective, observational cohort study was used to compare patients managed via hospital  to those managed o-line between December 2015 and 2016. The primary outcome was the percentage of time in the therapeutic range (TTR). The secondary outcomes were the incidence rates of hemorrhagic events, thrombotic events and extreme international normalized ratio (INR) values. Results A total of 152 patients were evaluated; 70 patients managed in a HAC were compared to 82 patients managed via an OAC. There were no significant differences in the TTR (78.9 vs. 74.0%, P = 0.393) and adverse events [major bleeding events (0 vs. 1.2%, P = 1.000), minor bleeding events (10.0 vs. 9.8%, P = 0.960), thromboembolic events (0 vs. 0%, P = 1.000), warfarin-related emergency visits (2.9 vs. 3.7%, P = 1.000)], warfarin-related hospital admissions (0 vs. 1.2%, P = 1.000), and the incidence of subtherapeutic (3.0 vs. 3.8%, P = 0.148), and extreme total (8.4 vs. 5.8%, P = 0.135), between the groups managed via HAC and OAC. Patients managed in the HAC were more stable on warfarin, with a higher percentage of INR values within the target therapeutic range (80.2 vs. 71.9%, P = 0.005) and a lower incidence of supratherapeutic INR values (8.4 vs. 18.5%, P = 0.001) compared to patients managed via OAC. Conclusion The management of oral anticoagulation therapy on-line yielded similar clinical outcomes compared to that achieved by management via the hospital, although the incidence of supra-therapeutic INR values was increased.
Literatur
1.
Zurück zum Zitat Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: chest guideline and expert panel report. Chest. 2016;149(2):315–52.CrossRef Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: chest guideline and expert panel report. Chest. 2016;149(2):315–52.CrossRef
2.
Zurück zum Zitat Downing A, Mortimer M, Hiers J. Impact of a pharmacist-driven warfarin management protocol on achieving therapeutic international normalized ratios. Am J Health Syst Pharm. 2016;73:69–73.CrossRef Downing A, Mortimer M, Hiers J. Impact of a pharmacist-driven warfarin management protocol on achieving therapeutic international normalized ratios. Am J Health Syst Pharm. 2016;73:69–73.CrossRef
3.
Zurück zum Zitat Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e152–84. https://doi.org/10.2146/sp150039.CrossRef Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e152–84. https://​doi.​org/​10.​2146/​sp150039.CrossRef
4.
Zurück zum Zitat Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes. Ann Pharmacother. 2008;42:777–82.CrossRef Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes. Ann Pharmacother. 2008;42:777–82.CrossRef
5.
Zurück zum Zitat Chau T, Rotbard M, King S, Li MM, Leong WA. Implementation and evaluation of a warfarin dosing service for rehabilitation medicine: report from a pilot project. Can J Hosp Pharm. 2006;59:136–47. Chau T, Rotbard M, King S, Li MM, Leong WA. Implementation and evaluation of a warfarin dosing service for rehabilitation medicine: report from a pilot project. Can J Hosp Pharm. 2006;59:136–47.
6.
Zurück zum Zitat Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641–7.CrossRef Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641–7.CrossRef
7.
Zurück zum Zitat Wallvik J, Sjalander A, Johansson L, Bjuhr O, Jansson JH. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care. 2007;25:123–8.CrossRef Wallvik J, Sjalander A, Johansson L, Bjuhr O, Jansson JH. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care. 2007;25:123–8.CrossRef
8.
Zurück zum Zitat Cryder BT, Felczak MA, Darkwa A, Patel H, Janociak JD, Rihani R. Transition of stable patients from traditional anticoagulation clinic services to telephonic management. Int J Clin Pharm. 2017;39:569–72.CrossRef Cryder BT, Felczak MA, Darkwa A, Patel H, Janociak JD, Rihani R. Transition of stable patients from traditional anticoagulation clinic services to telephonic management. Int J Clin Pharm. 2017;39:569–72.CrossRef
9.
Zurück zum Zitat Lee JC, Horner KE, Krummel ML, McDanel DL. Clinical and financial outcomes evaluation of multimodal pharmacist warfarin management of a statewide urban and rural population. J Pharm Pract. 2018;31(2):150–6.CrossRef Lee JC, Horner KE, Krummel ML, McDanel DL. Clinical and financial outcomes evaluation of multimodal pharmacist warfarin management of a statewide urban and rural population. J Pharm Pract. 2018;31(2):150–6.CrossRef
10.
Zurück zum Zitat Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, et al. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service-results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med. 2015;13:14.CrossRef Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, et al. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service-results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med. 2015;13:14.CrossRef
11.
Zurück zum Zitat McCahon D, Baker JM, Murray ET, Fitzmaurice DA. Assessing the utility of an online registry for patients monitoring their own warfarin therapy. J Clin Pathol. 2016;69:331–6.CrossRef McCahon D, Baker JM, Murray ET, Fitzmaurice DA. Assessing the utility of an online registry for patients monitoring their own warfarin therapy. J Clin Pathol. 2016;69:331–6.CrossRef
12.
Zurück zum Zitat Wittkowsky AK, Nutescu EA, Blackburn J, Mullins J, Hardman J, Mitchell J, et al. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic settings. Chest. 2006;130:1385–9.CrossRef Wittkowsky AK, Nutescu EA, Blackburn J, Mullins J, Hardman J, Mitchell J, et al. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic settings. Chest. 2006;130:1385–9.CrossRef
13.
Zurück zum Zitat Stoudenmire LG, DeRemer CE, Elewa H. Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes. Int J Hematol. 2014;100:119–24.CrossRef Stoudenmire LG, DeRemer CE, Elewa H. Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes. Int J Hematol. 2014;100:119–24.CrossRef
14.
Zurück zum Zitat Ryan F, Byrne S, O’Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an online consulting-based expert system. J Thromb Haemost. 2009;7:1284–90.CrossRef Ryan F, Byrne S, O’Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an online consulting-based expert system. J Thromb Haemost. 2009;7:1284–90.CrossRef
15.
Zurück zum Zitat Hassan S, Naboush A, Radbel J, Asaad R, Alkaied H, Demissie S, et al. Telephone-based anticoagulation management in the homebound setting: a retrospective observational study. Int J Gen Med. 2013;6:869–75.CrossRef Hassan S, Naboush A, Radbel J, Asaad R, Alkaied H, Demissie S, et al. Telephone-based anticoagulation management in the homebound setting: a retrospective observational study. Int J Gen Med. 2013;6:869–75.CrossRef
16.
Zurück zum Zitat Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005;127:1515–22.CrossRef Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest. 2005;127:1515–22.CrossRef
17.
Zurück zum Zitat Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62:601–9.CrossRef Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62:601–9.CrossRef
18.
Zurück zum Zitat Ahmed NO, Osman B, Abdelhai YM, El-Hadiyah TMH. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Int J Clin Pharm. 2017;39(4):769–73.CrossRef Ahmed NO, Osman B, Abdelhai YM, El-Hadiyah TMH. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Int J Clin Pharm. 2017;39(4):769–73.CrossRef
19.
Zurück zum Zitat Faircloth JM, Miner KM, Alsaied T, Nelson N, Ciambarella J, Mizuno T, et al. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients. J Thromb Thrombolysis. 2017;44:38–47.CrossRef Faircloth JM, Miner KM, Alsaied T, Nelson N, Ciambarella J, Mizuno T, et al. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients. J Thromb Thrombolysis. 2017;44:38–47.CrossRef
20.
Zurück zum Zitat Zhang J, Liu M, Chen Q, Wu J, Cao H. Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities. Thromb Res. 2017;157:136–8.CrossRef Zhang J, Liu M, Chen Q, Wu J, Cao H. Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities. Thromb Res. 2017;157:136–8.CrossRef
21.
Zurück zum Zitat Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62(5):601–9.CrossRef Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62(5):601–9.CrossRef
23.
Zurück zum Zitat Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.CrossRef Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.CrossRef
24.
Zurück zum Zitat Schulman S, Kearon C. Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Thromb Haemost. 2005;3:692–4.CrossRef Schulman S, Kearon C. Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Thromb Haemost. 2005;3:692–4.CrossRef
25.
Zurück zum Zitat Boman K, Davidson T, Gustavsson M, Olofsson M, Renström GB, Johansson L. Telemedicine improves the monitoring process in anticoagulant treatment. J Telemed Telecare. 2012;18:312–6.CrossRef Boman K, Davidson T, Gustavsson M, Olofsson M, Renström GB, Johansson L. Telemedicine improves the monitoring process in anticoagulant treatment. J Telemed Telecare. 2012;18:312–6.CrossRef
Metadaten
Titel
Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic
verfasst von
Hua Cao
Jianmei Wu
Jinhua Zhang
Publikationsdatum
01.10.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2018
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0674-0

Weitere Artikel der Ausgabe 5/2018

International Journal of Clinical Pharmacy 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.